Bifiform, 30 pcs.

Enterococcus faecium and Bifidobacterium longum strains included in the drug are natural symbiotic bacteria that inhabit the gastrointestinal tract. The drug has a normalizing effect on the quantitative and qualitative composition of the intestinal microflora.

The action is conditioned by direct direct effect of ingredients of the preparation (high antagonistic activity in respect of pathogenic and conditionally pathogenic microorganisms) and indirect – stimulation of local intestinal immunity (activation of immunoglobulin A synthesis, induction of endogenous interferon synthesis).

Bifidobacterium longum has high survival rate in human intestine and high growth rate. Inclusion of Enterococcus faecium apathogenic enterococcus that normally colonizes small intestine allows to have a positive effect on condition and digestive functions of not only large but also small intestine, especially in case of fermentative dyspepsia and flatulence phenomena.

Indications

Active ingredient

Composition

How to take, the dosage

Special Instructions

The maximum daily dose should not be exceeded.

Synopsis

Contraindications